Glypican-3 peptide reagents and methods
US11248022B2 · kind B2 · utility
0Cited by
3References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 7, 2018 |
| Grant date | Feb 15, 2022 |
| Priority date | — |
| Expiry date | Mar 7, 2038 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/52
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to glypican-3-specific peptide reagents, methods for detecting hepatocellular carcinoma cells using the peptide reagents, and methods for targeting hepatocellular carcinoma cells using the peptide reagents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.